Ul Solutions [ULS] vs Copart [CPRT] Detailed Stock Comparison
Ul Solutions
NYSE
Loading...
Copart
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ul Solutions wins in 7 metrics, Copart wins in 11 metrics, with 0 ties. Copart appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ul Solutions | Copart | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 43.05 | 31.20 | Copart |
| Price-to-Book Ratio | 14.84 | 5.19 | Copart |
| Debt-to-Equity Ratio | 85.67 | 1.15 | Copart |
| PEG Ratio | 42.54 | 27.07 | Copart |
| EV/EBITDA | 25.39 | 21.69 | Copart |
| Profit Margin (TTM) | 11.60% | 32.21% | Copart |
| Operating Margin (TTM) | 15.32% | 37.27% | Copart |
| EBITDA Margin (TTM) | 15.32% | 37.27% | Copart |
| Return on Equity | 42.71% | 18.44% | Ul Solutions |
| Return on Assets (TTM) | 10.40% | 12.02% | Copart |
| Free Cash Flow (TTM) | $287.00M | $961.57M | Copart |
| Dividend Yield | 0.52% | N/A | N/A |
| 1-Year Return | 30.31% | -9.57% | Ul Solutions |
| Price-to-Sales Ratio (TTM) | 4.96 | 9.92 | Ul Solutions |
| Enterprise Value | $15.01B | $41.29B | Copart |
| EV/Revenue Ratio | 5.17 | 8.99 | Ul Solutions |
| Gross Profit Margin (TTM) | 48.37% | 45.58% | Ul Solutions |
| Revenue per Share (TTM) | $15 | $5 | Ul Solutions |
| Earnings per Share (Diluted) | $1.67 | $1.51 | Ul Solutions |
| Beta (Stock Volatility) | N/A | 1.04 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ul Solutions vs Copart Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ul Solutions | 1.03% | -9.78% | -9.74% | -5.76% | 22.44% | 32.87% |
| Copart | 0.15% | 1.72% | -5.57% | -24.71% | -20.79% | -18.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ul Solutions | 30.31% | 87.26% | 87.26% | 87.26% | 87.26% | 87.26% |
| Copart | -9.57% | 41.92% | 84.44% | 913.41% | 2,064.79% | 3,015.54% |
Performance & Financial Health Analysis: Ul Solutions vs Copart
| Metric | ULS | CPRT |
|---|---|---|
| Market Information | ||
| Market Cap | $14.42B | $45.55B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 581,810 | 5,942,240 |
| 90 Day Avg. Volume | 749,880 | 6,856,360 |
| Last Close | $66.65 | $46.18 |
| 52 Week Range | $46.79 - $74.15 | $45.05 - $64.38 |
| % from 52W High | -10.11% | -28.27% |
| All-Time High | $74.15 (Jul 31, 2025) | $64.38 (Nov 25, 2024) |
| % from All-Time High | -10.11% | -28.27% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.08% |
| Quarterly Earnings Growth | 0.20% | 0.06% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.32% |
| Operating Margin (TTM) | 0.15% | 0.37% |
| Return on Equity (TTM) | 0.43% | 0.18% |
| Debt to Equity (MRQ) | 85.67 | 1.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.85 | $9.08 |
| Cash per Share (MRQ) | $1.33 | $4.53 |
| Operating Cash Flow (TTM) | $537.00M | $1.80B |
| Levered Free Cash Flow (TTM) | $220.75M | $873.61M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.52% | N/A |
| Last 12-Month Dividend | $0.37 | N/A |
Valuation & Enterprise Metrics Analysis: Ul Solutions vs Copart
| Metric | ULS | CPRT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 43.05 | 31.20 |
| Forward P/E | 42.54 | 27.07 |
| PEG Ratio | 42.54 | 27.07 |
| Price to Sales (TTM) | 4.96 | 9.92 |
| Price to Book (MRQ) | 14.84 | 5.19 |
| Market Capitalization | ||
| Market Capitalization | $14.42B | $45.55B |
| Enterprise Value | $15.01B | $41.29B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.17 | 8.99 |
| Enterprise to EBITDA | 25.39 | 21.69 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.04 |
| Book Value per Share (MRQ) | $4.85 | $9.08 |
Financial Statements Comparison: Ul Solutions vs Copart
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ULS | CPRT |
|---|---|---|
| Revenue/Sales | $705.00M | $1.21B |
| Cost of Goods Sold | $364.00M | $659.45M |
| Gross Profit | $341.00M | $552.27M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $109.00M | $451.55M |
| EBITDA | $154.00M | $506.07M |
| Pre-Tax Income | $94.00M | $502.80M |
| Income Tax | $23.00M | $97.47M |
| Net Income (Profit) | $71.00M | $405.34M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ULS | CPRT |
|---|---|---|
| Cash & Equivalents | $267.00M | $2.37B |
| Total Current Assets | $998.00M | $5.36B |
| Total Current Liabilities | $804.00M | $657.13M |
| Long-Term Debt | $803.00M | $81.27M |
| Total Shareholders Equity | $984.00M | $8.80B |
| Retained Earnings | $291.00M | $7.70B |
| Property, Plant & Equipment | $1.62B | $97.68M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ULS | CPRT |
|---|---|---|
| Operating Cash Flow | $240.00M | $704.64M |
| Capital Expenditures | N/A | $-124.08M |
| Free Cash Flow | $103.00M | $572.92M |
| Debt Repayment | $-152.00M | $-4,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ULS | CPRT |
|---|---|---|
| Shares Short | 2.61M | 28.63M |
| Short Ratio | 3.16 | 3.62 |
| Short % of Float | 0.05% | 0.04% |
| Average Daily Volume (10 Day) | 581,810 | 5,942,240 |
| Average Daily Volume (90 Day) | 749,880 | 6,856,360 |
| Shares Outstanding | 200.17M | 962.97M |
| Float Shares | 61.50M | 886.48M |
| % Held by Insiders | 0.01% | 0.09% |
| % Held by Institutions | 1.20% | 0.87% |
Dividend Analysis & Yield Comparison: Ul Solutions vs Copart
| Metric | ULS | CPRT |
|---|---|---|
| Last 12-Month Dividend | $0.37 | N/A |
| Last 12-Month Dividend Yield | 0.52% | N/A |
| 3-Year Avg Annual Dividend | $0.16 | N/A |
| 3-Year Avg Dividend Yield | 0.27% | N/A |
| 3-Year Total Dividends | $0.49 | N/A |
| Ex-Dividend Date | Feb 28, 2025 | N/A |